These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1603291)

  • 1. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree.
    Villardita C; Grioli S; Lomeo C; Cattaneo C; Parini J
    Neuropsychobiology; 1992; 25(1):24-8. PubMed ID: 1603291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological results of long-term therapy with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia in comparison with a control group.
    Parnetti L; Mecocci P; Petrini A; Longo A; Buccolieri A; Senin U
    Neuropsychobiology; 1989; 22(2):97-100. PubMed ID: 2518332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuropsychological study with oxiracetam versus placebo in patients with mild to moderate dementia.
    Villardita C; Parini J; Grioli S; Quattropani M; Lomeo C; Scapagnini U
    J Neural Transm Suppl; 1987; 24():293-8. PubMed ID: 3479527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxiracetam in the treatment of primary degenerative and multi-infarct dementia: a double-blind, placebo-controlled study.
    Maina G; Fiori L; Torta R; Fagiani MB; Ravizza L; Bonavita E; Ghiazza B; Teruzzi F; Zagnoni PG; Ferrario E
    Neuropsychobiology; 1989; 21(3):141-5. PubMed ID: 2693996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxiracetam in dementia: a double-blind, placebo-controlled study.
    Bottini G; Vallar G; Cappa S; Monza GC; Scarpini E; Baron P; Cheldi A; Scarlato G
    Acta Neurol Scand; 1992 Sep; 86(3):237-41. PubMed ID: 1414239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxiracetam in the treatment of multi-infarct dementia.
    Baumel B; Eisner L; Karukin M; MacNamara R; Katz RJ; Deveaugh-Geiss J
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):673-82. PubMed ID: 2781039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia.
    Dysken MW; Katz R; Stallone F; Kuskowski M
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):249-52. PubMed ID: 2521069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1993 Feb; 15(1):44-52. PubMed ID: 8456595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment trial of oxiracetam in Alzheimer's disease.
    Green RC; Goldstein FC; Auchus AP; Presley R; Clark WS; Van Tuyl L; Green J; Hersch SM; Karp HR
    Arch Neurol; 1992 Nov; 49(11):1135-6. PubMed ID: 1444879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selegiline versus oxiracetam in patients with Alzheimer-type dementia.
    Falsaperla A; Monici Preti PA; Oliani C
    Clin Ther; 1990; 12(5):376-84. PubMed ID: 2125242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of oxiracetam therapy in the treatment of cognitive deficiencies secondary to primary degenerative dementia.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1992 Apr; 14(2):117-26. PubMed ID: 1414555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of oxiracetam in patients with organic brain syndrome: a neuropsychological study.
    Moglia A; Sinforiani E; Zandrini C; Gualtieri S; Corsico R; Arrigo A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S73-8. PubMed ID: 3594459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
    Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study.
    Passeri M; Cucinotta D; Abate G; Senin U; Ventura A; Stramba Badiale M; Diana R; La Greca P; Le Grazie C
    Aging (Milano); 1993 Feb; 5(1):63-71. PubMed ID: 8257478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS pharmacology and clinical therapeutic effects of oxiracetam.
    Itil TM; Menon GN; Songar A; Itil KZ
    Clin Neuropharmacol; 1986; 9 Suppl 3():S70-2. PubMed ID: 3594458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.